MX9503363A - Phtalmide n-(2,6-dioxo-3-piperidyl)(generic talydomide as treatment of the worn syndrome associated with the infection by hiv-1. - Google Patents

Phtalmide n-(2,6-dioxo-3-piperidyl)(generic talydomide as treatment of the worn syndrome associated with the infection by hiv-1.

Info

Publication number
MX9503363A
MX9503363A MX9503363A MX9503363A MX9503363A MX 9503363 A MX9503363 A MX 9503363A MX 9503363 A MX9503363 A MX 9503363A MX 9503363 A MX9503363 A MX 9503363A MX 9503363 A MX9503363 A MX 9503363A
Authority
MX
Mexico
Prior art keywords
dioxo
worn
piperidyl
hiv
generic
Prior art date
Application number
MX9503363A
Other languages
Spanish (es)
Other versions
MXPA95003363A (en
Inventor
Gustavo Reyes Teran
Guillermo Ruiz-Palacios
Juan Sierra-Madero
Original Assignee
Inst Nac De La Nutricion Salva
Zubiran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nac De La Nutricion Salva, Zubiran filed Critical Inst Nac De La Nutricion Salva
Priority to MXPA/A/1995/003363A priority Critical patent/MXPA95003363A/en
Priority claimed from MXPA/A/1995/003363A external-priority patent/MXPA95003363A/en
Publication of MX9503363A publication Critical patent/MX9503363A/en
Publication of MXPA95003363A publication Critical patent/MXPA95003363A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to the use of 2-(2,6-dioxo-3-piperidinyl)-1H-isoindol-1-1,3 (2H)-dione; N-(2,6-dioxo-3-piperidyl)phtalimide; a-phtalimidoglutarimide (generic Talidomide) in the treatment of worn syndrome (WS) in patients in the final stage, affected by HIV-1 (AIDS) or any disease (example: cancer) wherein said worn syndrome is manifested as complication of the same suffering and its possible therapeutic association with other useful chemical entities in these sufferings.
MXPA/A/1995/003363A 1995-08-04 N- (2,6-dioxo-3-piperidil) ftalimide (generic talidomide as treatment of the wear syndrome associated with infection by vi MXPA95003363A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MXPA/A/1995/003363A MXPA95003363A (en) 1995-08-04 N- (2,6-dioxo-3-piperidil) ftalimide (generic talidomide as treatment of the wear syndrome associated with infection by vi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/1995/003363A MXPA95003363A (en) 1995-08-04 N- (2,6-dioxo-3-piperidil) ftalimide (generic talidomide as treatment of the wear syndrome associated with infection by vi

Publications (2)

Publication Number Publication Date
MX9503363A true MX9503363A (en) 1998-07-31
MXPA95003363A MXPA95003363A (en) 1998-11-09

Family

ID=

Similar Documents

Publication Publication Date Title
TNSN04113A1 (en) 3-รข-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
DK0642513T3 (en) Indole carbazolimides and their use
WO2002002518A3 (en) Compounds to treat alzheimer's disease
DE60236413D1 (en) INHIBITORS OF HMGB1 FOR THE TREATMENT OF TISSUE DISEASES
WO2002002520A8 (en) Compounds to treat alzheimer's disease
EA200201247A1 (en) CONNECTIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DE69400799D1 (en) USE OF RILUZOL FOR THE TREATMENT OF PARKINSON AND THE PARKINSON SYNDROME
TR200200260T2 (en) Production and usage methods of N-desmethylzopiclones
DK1289535T3 (en) Apoptotic devices for use in the treatment of neurodegenerative and other neurological diseases
NO20005757L (en) Cabergoline and pramipexole - new uses and combinations
MD970254A (en) Use of melatonine for treatment of patients having a medicamental dependence
ZA968783B (en) Flupirtine usage
MX9503363A (en) Phtalmide n-(2,6-dioxo-3-piperidyl)(generic talydomide as treatment of the worn syndrome associated with the infection by hiv-1.
DE60006519D1 (en) GLUTATHION REDUCTASE FOR THE TREATMENT AND PROPHYLAXIS OF AIDS
HUP0004647A2 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
DK0703781T3 (en) Use of Efaroxan and its Derivatives for the Preparation of a Drug to Treat Parkinson's Disease
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
EP1370697A4 (en) Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof
EA199800941A1 (en) THERAPEUTICALLY MEANS CONTAINING OXYGEN ANION-RADICALS AND / OR PRODUCTS OF THEIR SUBSEQUENTAL TURNING AND DIVISION AND THEIR APPLICATION FOR THE TREATMENT OF PARKINSON'S DISEASE
DE60129846D1 (en) ISOCHINOLINE-AROYLPYRROLE FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
MX9503783A (en) Ammonium chloride compounds combinations for the treatment of viral infections.